批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/04/20 |
SUPPL-86(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/20 |
SUPPL-82(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/20 |
SUPPL-80(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/02/17 |
SUPPL-84(补充) |
Approval |
Manufacturing (CMC) |
UNKNOWN
|
|
|
2019/11/06 |
SUPPL-76(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/06/14 |
SUPPL-75(补充) |
Approval |
Manufacturing (CMC) |
UNKNOWN
|
|
|
2016/01/05 |
SUPPL-73(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/05 |
SUPPL-68(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/03 |
SUPPL-53(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2001/09/05 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2000/04/21 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2000/03/27 |
SUPPL-51(补充) |
Approval |
Labeling |
|
|
|
1999/12/01 |
SUPPL-49(补充) |
Approval |
Labeling |
|
|
|
1998/08/26 |
SUPPL-48(补充) |
Approval |
Labeling |
|
|
|
1998/02/25 |
SUPPL-46(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/02/05 |
SUPPL-47(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/12/17 |
SUPPL-45(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/06/09 |
SUPPL-43(补充) |
Approval |
Labeling |
|
|
|
1991/05/30 |
SUPPL-42(补充) |
Approval |
Labeling |
|
|
|
1990/04/04 |
SUPPL-41(补充) |
Approval |
Labeling |
|
|
|
1990/01/31 |
SUPPL-38(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1984/09/18 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1982/03/18 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1979/08/03 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 剂型/给药途径:TABLET;ORAL 规格:25MG;25MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
086513 |
001 |
ANDA |
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
TABLET;ORAL |
25MG;25MG |
Prescription |
No |
No |
AB |
Approved Prior to Jan 1, 1982
|
MYLAN |
012616 |
004 |
NDA |
ALDACTAZIDE |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
TABLET;ORAL |
25MG;25MG |
Prescription |
Yes |
No |
AB |
1982/12/30
|
PFIZER |
089534 |
001 |
ANDA |
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
TABLET;ORAL |
25MG;25MG |
Prescription |
No |
No |
AB |
1987/07/02
|
SUN PHARM INDUSTRIES |